HydroxychloroquineQTc prolongation following off-label use: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1829卷 / 1期

关键词：

D O I：

10.1007/s40278-020-85786-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：196 / 196

相关论文

共 50 条

[21] NivolumabFever following off-label use: case report [J].

Reactions Weekly, 2016, 1601 (1) :186-186

[22] DexamfetamineHypertension following off-label use: case report [J].

Reactions Weekly, 2021, 1883 (1) :150-150

[23] MirtazapineTachyphylaxis following off-label use: case report [J].

Reactions Weekly, 2018, 1703 (1) :182-182

[24] TocilizumabAnaphylaxis following off-label use: case report [J].

Reactions Weekly, 2021, 1865 (1) :397-397

[25] RituximabPancytopenia following off-label use: case report [J].

Reactions Weekly, 2020, 1807 (1) :176-176

[26] NivolumabPsoriasis following an off-label use: case report [J].

Reactions Weekly, 2018, 1717 (1) :214-214

[27] PrednisoloneInefficacy following off-label use: case report [J].

Reactions Weekly, 2022, 1910 (1) :405-405

[28] DaratumumabHypogammaglobulinemia following off-label use: case report [J].

Reactions Weekly, 2019, 1744 (1) :111-111

[29] SunitinibCardiomyopathy following off-label use: case report [J].

Reactions Weekly, 2023, 1971 (1) :240-240

[30] GlibenclamideHypoglycaemia following off-label use: case report [J].

Reactions Weekly, 2021, 1857 (1) :162-162

← 1 2 3 4 5 →